A detailed history of Net Worth Advisory Group transactions in Abb Vie Inc. stock. As of the latest transaction made, Net Worth Advisory Group holds 3,825 shares of ABBV stock, worth $895,050. This represents 0.26% of its overall portfolio holdings.

Number of Shares
3,825
Previous 6,110 37.4%
Holding current value
$895,050
Previous $1.13 Billion 21.91%
% of portfolio
0.26%
Previous 0.25%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025

SELL
$184.85 - $231.54 $422,382 - $529,068
-2,285 Reduced 37.4%
3,825 $886 Million
Q2 2025

Jul 21, 2025

BUY
$170.16 - $206.27 $414,169 - $502,061
2,434 Added 66.21%
6,110 $1.13 Billion
Q1 2025

Apr 15, 2025

BUY
$169.2 - $216.66 $15,397 - $19,716
91 Added 2.54%
3,676 $770 Million
Q4 2024

Feb 07, 2025

BUY
$164.99 - $203.87 $3,959 - $4,892
24 Added 0.67%
3,585 $637 Million
Q3 2024

Oct 17, 2024

BUY
$163.84 - $199.33 $583,434 - $709,814
3,561 New
3,561 $703 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Net Worth Advisory Group Portfolio

Follow Net Worth Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Net Worth Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Net Worth Advisory Group with notifications on news.